TickerFacts.

Rapport Therapeutics, Inc. (RAPP): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.02M
Year ended 2025-12-31
$960.0K
Trailing 12 months to 2026-06-30
2023-12-31: $112.0K2024-12-31: $839.0K2025-12-31: $1.02M$1.02M
2023-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.02M+21.2%2026-03-10, From 2025-01-01
2024-12-31$839.0K+649.1%2026-03-10, From 2024-01-01
2023-12-31$112.0Kn/a2025-03-11, From 2023-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Rapport Therapeutics, Inc. (RAPP)2025-12-31$1.02M+21.2%
Rigel Pharmaceuticals Inc (RIGL)2025-12-31$2.42M+8.4%
Ardelyx, Inc. (ARDX)2025-12-31$3.06M+48.3%
Olema Pharmaceuticals, Inc. (OLMA)2025-12-31$490.0K+24.7%
Rhythm Pharmaceuticals, Inc. (RYTM)2025-12-31$500.0K-28.6%
Enliven Therapeutics, Inc. (ELVN)2025-12-31$300.0K0.0%
Standard Biotools Inc. (LAB)2025-12-31$9.26M-26.0%
Geron Corp (GERN)2025-12-31$474.0K-13.2%
Biohaven Ltd. (BHVN)2025-12-31$9.92M+26.3%

Compare RAPP, RIGL, ARDX, OLMA side by side · Screen every company in Pharmaceutical Preparations ↗